Healthcare and Biotech Insights

From early stage trials to commercial launches, this page tracks the moments that can change a company’s outlook overnight. Expect timely headlines, clear context, and investor focused analysis on approvals, data readouts, partnerships, and funding moves across biotech, pharma, medtech, and digital health.

A New Biotech Partnership Puts Tenaya Therapeutics (NASDAQ: TNYA) Back on the Radar

Tenaya Therapeutics (NASDAQ: TNYA) Back on the Radar

February 26, 2026

This Cultural Shift Could Ignite a Huge Biotech Rally

This Cultural Shift Could Ignite a Huge Biotech Rally

February 24, 2026

Vir Biotechnology (NASDAQ: VIR) Soars 27.7% on Big Pharma Deal

Vir Biotechnology (NASDAQ: VIR)

February 17, 2026

Why Compass Pathways (NASDAQ: CMPS) Could Be the Biotech Breakout of 2026

Compass Pathways (NASDAQ: CMPS)

February 10, 2026

This Is the Breakthrough Moment for Evommune (NYSE: EVMN)

Evommune (NYSE: EVMN)

February 2, 2026

Why Hain Celestial (NASDAQ: HAIN) Is Suddenly Back From the Dead

Hain Celestial (NASDAQ: HAIN)

More articles

January 29, 2026

Serina Therapeutics (NYSE: SER) Rallies on FDA Clearance

Serina Therapeutics (NYSE: SER) Rallies on FDA Clearance

January 13, 2026

BioAge (NASDAQ: BIOA) Jumps as Early Data Validates Its Science

BioAge (NASDAQ: BIOA) Jumps as Early Data Validates Its Science

January 13, 2026

Why Outset Medical Is Back on Investors’ Radar

Why Outset Medical Is Back on Investors’ Radar

December 26, 2025

Shingles, Hep-B, and Billions in Upside – The Real Reason Sanofi Grabbed Dynavax

Sanofi Scores Major Deal with Dynavax Acquisition

December 23, 2025

Trinity Biotech (NASDAQ: TRIB) Secures Major HIV Diagnostics Order – Shares Surge

Trinity Biotech (NASDAQ: TRIB) Secures Major HIV Diagnostics Order

December 12, 2025

Federal Reclassification Could Put Pot Stocks Back on Wall Street’s Radar

Pot Stocks Get a Major Boost

November 25, 2025

Anavex (NASDAQ: AVXL) Soars Double Digits on Earnings. But is that enough to save this Beaten-Down Biotech?

Anavex Narrows Loss

November 13, 2025

While the Dow fell 797 points, THIS biotech stock soared 209%

Mersana Therapeutics

November 6, 2025

Compass Pathways (NASDAQ: CMPS) Hits the Accelerator, But The Stakes Remain High

Compass Pathways

October 31, 2025

CYBIN (NYSE: CYBN) Offers Quick Gains on Psychedelics Bull Market

Cybin, Inc.

Why Boring Health Insurers Might Quietly Crush the Market in 2025

Why Boring Health Insurers Might Quietly Crush the Market in 2025

Why Rare Disease Biotechs Could Be the Smartest Bet of the Decade

Why Rare Disease Biotechs Could Be the Smartest Bet of the Decade

Why Healthcare Stocks Still Anchor Long-Term Portfolios

Why Healthcare Stocks Still Anchor Long-Term Portfolios

Why the Biotech Sector Is Quiet Now — and Why That Might Change Soon

Why the Biotech Sector Is Quiet Now — and Why That Might Change Soon

Why Small-Cap Drug Developers Are Back on Wall Street’s Radar

Why Small-Cap Drug Developers Are Back on Wall Street’s Radar

PSG Equity's Move Suggests Something

PSG Equity's Move Suggests Something

Tonix Pharmaceuticals Gains 96%

Tonix Pharmaceuticals Gains 96%

February 19, 2025

Wave Life Sciences Jumps 51%

Wave Life Sciences Jumps 51 Percent

February 19, 2025

MAIA Biotechnology Makes Noise With New Lung Cancer Data

MAIA Biotechnology Makes Noise With New Lung Cancer Data

February 16, 2025

Vera Therapeutics Builds Momentum With Strong Kidney Drug Data

Vera Therapeutics Builds Momentum With Strong Kidney Drug Data

February 10, 2025

The Real Innovation Isn’t Coming From Big Pharma

The Real Innovation Isn’t Coming From Big Pharma

February 8, 2025

Viking Therapeutics Takes Aim at Weight-Loss Market Leaders

Viking Therapeutics Takes Aim at Weight-Loss Market Leaders

February 1, 2025

Solvonis Gains 32 Percent (Top Biotech Small-Cap)

Solvonis Gains 32 Percent (Top Biotech Small-Cap)

Where Smart Money Is Quietly Moving in Healthcare

Where Smart Money Is Quietly Moving in Healthcare

Get free premium insights
in our latest report

Tablet and smartphone displaying a digital report titled 'The Orbital Gold Rush' with an author bio and photo of a man in a blue shirt and tie.

Discover other articles

November 27, 2025

The Olympics Don’t Want This… But Investors Do: Enhanced Games to List on Public Markets

The Enhanced Games is going public

November 19, 2025

Semrush (NYSE: SEMR) Acquisition Delivers 73.9% Gains Within Minutes!

SEMR stock soars on acquisition news

February 4, 2025

Riding the AI Boom and Dodging Market Traps

Riding the AI Boom

February 13, 2026

Rivian (NASDAQ: RIVN) Rally Signals a Bigger Move Ahead

Rivian (NASDAQ: RIVN)

December 17, 2025

The Real Reason Udemy (NASDAQ: UDMY) Jumped Today

Udemy stock soars

What The Wolf of Wall Street Really Did to the Investing World

What The Wolf of Wall Street Really Did to the Investing World

Broadcom Stock Climbs Toward Record High as Earnings Buzz Builds

Broadcom Stock Climbs Toward Record High as Earnings Buzz Builds

December 10, 2025

PowerBank (NASDAQ: SUUN) Just Took a Big Step Forward

$168M for PowerBank

Designer Brands: What Do They Know That Wall Street Doesn’t?

Designer Brands Executives Are Buying Stock—What Do They Know That Wall Street Doesn’t?

Oil, Volatility, and Risk: That’s Tomorrow’s Setup

Oil, Volatility, and Risk: That’s Tomorrow’s Setup

Chime’s IPO Signals a Return to Realistic Fintech Valuations

Chime’s IPO Signals a Return to Realistic Fintech Valuations

February 2, 2026

SPACs in Space: Why Space Asset Acquisition Corp (NASDAQ: SAAQU) Matters

Why Space Asset Acquisition Corp (NASDAQ: SAAQU) Matters